Related Experiment Video
Updated: Nov 20, 2025

07:18
Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
Published on: November 9, 2018
8.6K
Severe oligomeric tau toxicity can be reversed without long-term sequelae
Alfonso Martinisi1,2, Martin Flach1,2, Frederik Sprenger1,2
1Institute of Medical Genetics and Pathology, University Hospital Basel, CH-4031 Basel, Switzerland.
Brain : a Journal of Neurology
|January 23, 2021
Summary
Toxic tau species can cause reversible paralysis and neuronal dysfunction in mice. Recovered mice showed no long-term motor deficits or increased tau pathology, indicating effective clearance without seeding effects.
Area of Science:
- Neuroscience
- Molecular Biology
- Neurodegenerative Diseases
Background:
- Tau protein stabilizes microtubules but forms toxic aggregates in neurodegenerative disorders like Alzheimer's disease.
- Previous studies demonstrated reversible paralysis in mice upon co-expression of fragmented and full-length tau.
Purpose of the Study:
- To investigate the long-term motor function and tau pathology in mice recovered from tau-induced paralysis.
- To assess the seeding competence of toxic oligomeric tau species.
Main Methods:
- Studied long-term motor fitness in recovered P301SxTAU62on-off mice.
- Inoculated ALZ17 mice with brainstem homogenates from paralyzed P301SxTAU62on mice to evaluate seeding potential.
Main Results:
- Recovered mice did not exhibit increased motor impairment or tau pathology compared to controls.
- Toxic tau species were cleared effectively without inducing seeding effects.
- Inoculated ALZ17 mice showed no long-term tau seeding effects from these toxic species.
Conclusions:
- Neurotoxic tau species can exist independently of seeding-competent aggregates.
- Complete clearance of toxic tau forms is possible without subsequent seeding or spreading.
- Targeting non-fibrillar tau species may offer therapeutic benefits for tauopathies.
- The lack of seeding competence in early toxic tau species suggests caution in using seeding-based diagnostic tests.
Related Concept Videos
Alzheimer's Disease: Treatment
586
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
586
Long-term Depression
2.8K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.8K
Long-term Depression
32.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
32.4K
Long-term Potentiation
57.2K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre- and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
57.2K
Long-term Potentiation
3.1K
Long-term potentiation, or LTP, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTP is the process of synaptic strengthening that occurs over time between pre and postsynaptic neuronal connections. The synaptic strengthening of LTP works in opposition to the synaptic weakening of long-term depression (LTD) and together are the main mechanisms that underlie learning and memory.
Hebbian LTP
LTP can occur when...
Hebbian LTP
LTP can occur when...
3.1K

